Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients.


Journal Article

Nephropathy due to BK virus (BKV) infection is an evolving challenge in patients undergoing hematopoietic stem cell transplantation (HSCT). We hypothesized that BKV infection was a marker of kidney function decline and a poor prognostic factor in HSCT recipients who experience this complication. In this retrospective study, we analyzed all patients who underwent their first allogeneic HSCT at our institution between 2004 and 2012. We evaluated the incidence of persistent kidney function decline, which was defined as a confirmed reduction in estimated glomerular filtration rate of at least 25% from baseline using the Chronic Kidney Disease Epidemiology equation. Cox proportional hazard regression was used to model the cause-specific hazard of kidney function decline, and the Fine-Gray method was used to account for the competing risks of death. Among 2477 recipients of a first allogeneic HSCT, BK viruria was detected in 25% (n = 629) and kidney function decline in 944 (38.1%). On multivariate analysis, after adjusting for age, sex, acute graft-versus-host disease (GVHD), chronic GVHD, preparative conditioning regimen, and graft source, BK viruria remained a significant risk factor for kidney function decline (p < 0.001). In addition, patients with BKV infection and kidney function decline experienced worse overall survival. After allogeneic HSCT, BKV infection was strongly and independently associated with subsequent kidney function decline and worse patient survival after HSCT.

Full Text

Duke Authors

Cited Authors

  • Abudayyeh, A; Hamdi, A; Lin, H; Abdelrahim, M; Rondon, G; Andersson, BS; Afrough, A; Martinez, CS; Tarrand, JJ; Kontoyiannis, DP; Marin, D; Gaber, AO; Salahudeen, A; Oran, B; Chemaly, RF; Olson, A; Jones, R; Popat, U; Champlin, RE; Shpall, EJ; Winkelmayer, WC; Rezvani, K

Published Date

  • May 2016

Published In

Volume / Issue

  • 16 / 5

Start / End Page

  • 1492 - 1502

PubMed ID

  • 26608093

Pubmed Central ID

  • 26608093

Electronic International Standard Serial Number (EISSN)

  • 1600-6143

Digital Object Identifier (DOI)

  • 10.1111/ajt.13635


  • eng

Conference Location

  • United States